{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_15", "age_group": "41_50", "agreed": true, "close_date_time": "2021-10-23 11:5:38", "close_timestamp": 1637665538257, "created": "23/11/2021 11:05:39", "department": "Sociology", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "4ea64f10-0fd0-4fa5-b6e8-322ccefb5803", "open_date_time": "2021-10-23 10:58:42", "open_timestamp": 1637665122700, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "A new antiviral drug called Invermectin has been unveiled by a team of scientists at Monash University headed by Dr Kylie Wagstaff. The drug has been found to kill the Covid-19 virus within 48 hours in research trials. ", "task_condition": "viz", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "post_graduate_phd", "time_taken_in_seconds": 415557, "what": "An antiviral drug that can supposedly kill the covid-19 virus.", "when_happened": "today", "where_location": "Monash University ", "who": "Dr Kylie Wagstaff", "why": "A new treatment discovered that can potentially help in the fight against the covid-19 virus."}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_15", "age_group": "41_50", "agreed": true, "close_date_time": "2021-10-23 11:29:0", "close_timestamp": 1637666940333, "created": "23/11/2021 11:29:02", "department": "Sociology", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "1f2b0f01-65ef-42a6-80e5-fe59ec51ca6b", "open_date_time": "2021-10-23 11:15:31", "open_timestamp": 1637666131224, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "The new vaccine Novavax has shown positive success rate in trials of patients with the Covid-19 virus. The Novavax vaccine has an almost 100% success rate in limiting the most severe symptoms caused by the virus. ", "task_condition": "text", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "post_graduate_phd", "time_taken_in_seconds": 809109, "what": "The discovery and potential implementation of a new vaccine to reduce the potentially deathly impact of the Covid-19 virus.", "when_happened": "today", "where_location": "USA and Mexico", "who": "Novavax, GlobalData, Ms Jaser, USA, Mexico, Serum Institute of India, GAVI.", "why": "A key development announced for a new vaccine that has shown very positive results in trials to help with the fight against the Covid-19 global pandemic."}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_15", "age_group": "41_50", "agreed": true, "close_date_time": "2021-10-23 11:15:12", "close_timestamp": 1637666112378, "created": "23/11/2021 11:15:13", "department": "Sociology", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "9daca35a-53d3-4772-a23a-8fa1e0058fa6", "open_date_time": "2021-10-23 11:6:36", "open_timestamp": 1637665596941, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "Professor Borody, a gastroenterologist in Sydney is leading a challenge to allow for the provision of a triple antiviral therapy that he argues may help cure patients battling illness caused by the Covid-19 virus.", "task_condition": "text", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "post_graduate_phd", "time_taken_in_seconds": 515437, "what": "A new triple viral therapy to help cure patients with the covid-19 virus.", "when_happened": "today", "where_location": "Australia", "who": "Professor Borody, Dr Kylie Wagstaff, Australian GP's, US FDA, WHO, Australian Politicans", "why": "A new announcement of a potential treatment that could be made available to help cure patients that are sick with the covid-19 virus."}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_15", "age_group": "41_50", "agreed": true, "close_date_time": "2021-10-23 10:58:28", "close_timestamp": 1637665108622, "created": "23/11/2021 10:58:30", "department": "Sociology", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "c2226c78-199e-4cf5-9996-d71ef85250f1", "open_date_time": "2021-10-23 10:52:15", "open_timestamp": 1637664735967, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "The Japanese Government has today announced the implementation of a country-wide vaccination programme in an attempt to combat the spread of the covid-19 virus amongst the population of Japan.", "task_condition": "viz", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "post_graduate_phd", "time_taken_in_seconds": 372655, "what": "Covid-19 Pandemic and Vaccine", "when_happened": "today", "where_location": "Japan", "who": "Dr Osamu Okade, President of Japan, Executives of Pharmaceutical Corporations, Government Officials", "why": "Global health pandemic, fight against a new potentially deathly virus"}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_15", "age_group": "41_50", "agreed": true, "close_date_time": "2021-10-23 12:11:29", "close_timestamp": 1637669489978, "created": "23/11/2021 12:11:31", "department": "Sociology", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "95e86910-b7be-45e2-9a94-c696fae4f932", "open_date_time": "2021-10-23 11:57:55", "open_timestamp": 1637668675950, "summary": "The drug company that produce one of three new Covid-19 vaccines - Pfizer - continues to go from strength to strength as they announce positive results from vaccination trials in young people. The US pharma giant Pfizer in collaboration with their German partner BioNTech has already had approval for the administration of the vaccine in people aged 16 years and older in the US. The Pfizer vaccine along with the BioNTech vaccine has now been approved for use in Canada for young people aged between 12 and 15 years old by  the Canadian medicines regulator.", "task_condition": "text", "task_key": "pfizer", "task_level": "post_graduate_phd", "time_taken_in_seconds": 814028}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_15", "age_group": "41_50", "agreed": true, "close_date_time": "2021-10-23 11:56:2", "close_timestamp": 1637668562737, "created": "23/11/2021 11:56:04", "department": "Sociology", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-23", "gender": "female", "id": "c6f6d7b1-ffc6-47e5-9844-14576bf89432", "open_date_time": "2021-10-23 11:36:55", "open_timestamp": 1637667415244, "summary": "One of the three new vaccines helping combat the most severe symptoms of the Covid-19 virus - AstraZeneca - continue to make Headline News across the world. \r\nThe discovery of a new 'Delta' variant of the Covid-19 virus has raised a major question about whether the new vaccines will still be as effective in fighting the virus. \r\nHowever, evidence has emerged in the UK that indeed all three coronavirus vaccines - Pfizer, BioNTech and AstraZeneca have still found to be extremely effective in combating the most serious consequences in patients with the Delta variant of the virus.\r\n", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "post_graduate_phd", "time_taken_in_seconds": 1147493}}}